SCHEMBL22285875

SCHEMBL22285875

Cc1cc2c(cc1C)n(CC(O)C(O)C(O)CO)c(=O)c(=O)n2Cc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 6/20 0.45
▸ KMT2A Q03164 6/20 0.45
▸ KDM4E B2RXH2 5/20 0.45
▸ ALDH1A1 P00352 5/20 0.45
▸ TDP1 Q9NUW8 4/20 0.45
▸ HSD17B10 Q99714 3/20 0.45
▸ HPGD P15428 3/20 0.45
▸ USP2 O75604 2/20 0.45
▸ CASP1 P29466 2/20 0.45
▸ BRCA1 P38398 2/20 0.45
▸ RECQL P46063 2/20 0.45
▸ CASP7 P55210 2/20 0.45
▸ LMNA P02545 2/20 0.45
▸ MAPT P10636 2/20 0.45
▸ MAPK1 P28482 2/20 0.45
▸ HTT P42858 1/20 0.45
▸ HBB P68871 1/20 0.45
▸ HAT1 O14929 1/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19411273 1.00 MEN1 (0.45) MEN1KMT2AKDM4EALDH1A1TDP1
SCHEMBL22285880 0.84 TDP1 (0.50) MEN1KMT2AKDM4EALDH1A1TDP1
SCHEMBL19411265 0.84 TDP1 (0.50) MEN1KMT2AKDM4EALDH1A1TDP1
SCHEMBL22285882 0.78 TDP1 (0.47) MEN1KMT2AKDM4EALDH1A1TDP1
SCHEMBL19411266 0.78 KMT2A (0.47) MEN1KMT2AKDM4EALDH1A1TDP1
SCHEMBL22285876 0.78 KMT2A (0.47) MEN1KMT2AKDM4EALDH1A1TDP1
SCHEMBL19411259 0.78 TDP1 (0.47) MEN1KMT2AKDM4EALDH1A1TDP1
SCHEMBL19411272 0.77 TDP1 (0.46) MEN1KMT2AKDM4EALDH1A1TDP1
SCHEMBL22285884 0.77 TDP1 (0.46) MEN1KMT2AKDM4EALDH1A1TDP1
SCHEMBL22285881 0.76 TDP1 (0.43) MEN1KMT2AKDM4EALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11002524-B2 Cyclic compounds and process for the preparation thereof COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2021-05-11 — — US claimed
US-20200249002-A9 A CYCLIC COMPOUNDS AND PROCESS FOR THE PREPARATION THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2020-08-06 — — US claimed
US-11002524-B2 Cyclic compounds and process for the preparation thereof COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2021-05-11 — — US disclosed
US-20200249002-A9 A CYCLIC COMPOUNDS AND PROCESS FOR THE PREPARATION THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2020-08-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11002524-B2 Cyclic compounds and process for the preparation thereof VIP, TREH, CCKAR MEN1 500/4885KMT2A 4261/4885KDM4E 3109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback